Early diagnosis and successful long-term management of a rare, severe lysosomal acid lipase deficiency/Wolman disease patient: Infancy to age five [0.03%]
罕见的溶酶体酸性脂酶缺乏症/沃尔曼病患者的早期诊断和长期成功管理：从婴儿期到五岁
Antoine Cossette,Julie Castilloux,Chantal Bouffard et al.
Antoine Cossette et al.
Background: This report describes a unique case of long-term survival of a young girl who was diagnosed with severe, rapidly progressive lysosomal acid lipase deficiency (LAL-D; historically "Wolman disease") at three mon...
Birth cohort hepatitis C antibody prevalence in real-world screening settings in Ontario [0.03%]
安大略省现实筛查环境中各出生队列的丙型肝炎抗体流行率
Mia J Biondi,Grishma Hirode,Camelia Capraru et al.
Mia J Biondi et al.
Background: Widespread screening and treatment of hepatitis C virus (HCV) is required to decrease late-stage liver disease and liver cancer. Clinical practice guidelines and Canadian Task Force on Preventative Health Care...
Natasha Chandok,Esther Provost,Iram Siddiqui
Natasha Chandok
Early predictors of unfavourable outcome in progressive cholestasis of northwestern Quebec [0.03%]
魁北克西北地区进行性胆汁郁积不良预后的早期预测因素
Léticia Khendek,Candice Diaz,Eric Drouin et al.
Léticia Khendek et al.
Background: Progressive cholestasis of northwestern Quebec (PCNQ) is a rare and severe form of cirrhosis affecting children from Quebec's First Nations. First described by our group in 1981 and historically named North Am...
The mean attributable health care costs associated with hepatitis B virus in Ontario, Canada: A matched cohort study [0.03%]
加拿大安大略省乙型肝炎病毒感染相关的平均医疗费用：队列匹配研究
Natasha Nanwa,Jeffrey C Kwong,Jordan J Feld et al.
Natasha Nanwa et al.
Background: No Canadian studies examined the economic impact of hepatitis B virus (HBV) using population-based, patient-level data. We determined attributable costs associated with HBV from a health care payer perspective...
Uptake and factors associated with direct-acting antiviral therapy for hepatitis C and treatment outcomes among Canadian immigrants: A retrospective cohort analysis [0.03%]
加拿大移民的直接抗病毒治疗丙型肝炎的接受情况及其相关因素和治疗结果：一项回顾性队列分析
Yelena Petrosyan,John-Graydon Simmons,Erin Kelly et al.
Yelena Petrosyan et al.
Background: We sought to compare rates and factors associated with direct acting antiviral (DAA) treatment uptake and sustained virological response (SVR) between Canadian-born and foreign-born patients. ...
A collaborative approach to hepatitis C testing in two First Nations communities of northwest Ontario [0.03%]
Ontario西北两个第一民族社区中丙型肝炎检测的协作方法
David Smookler,Anne Beck,Brenda Head et al.
David Smookler et al.
Background: Two remote First Nations communities each collaborated with an urban-based liver clinic to organize wide-spread testing, followed by linkage to care for hepatitis C virus (HCV). ...
Hepatocellular carcinoma screening practices among patients with chronic hepatitis B by Canadian gastroenterologists and hepatologists: An online survey [0.03%]
加拿大胃肠病学家和肝病学家对慢性乙型肝炎患者的肝细胞癌筛查实践：一项在线调查
Alan Hoi Lun Yau,Cherry Galorport,Carla S Coffin et al.
Alan Hoi Lun Yau et al.
Background: xpert guidelines recommend hepatocellular carcinoma (HCC) surveillance among patients with high-risk chronic hepatitis B (CHB); however, physician screening practices are often variable. ...
Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant [0.03%]
2018年加拿大肝脏研究协会单一主题会议论文集：肝硬化的临床到移植-从失代偿期肝硬化起步
Victor Dong,Maxime Gosselin,Nishita Jagarlamudi et al.
Victor Dong et al.
The Canadian Liver Foundation celebrates 50 years of commitment to hepatology [0.03%]
加拿大肝病基金会庆祝对肝脏学承诺的50周年纪念日
Eve A Roberts,M M Fisher
Eve A Roberts
Founded in 1969, the Canadian Liver Foundation (CLF) was the first foundation worldwide to support research and education relating specifically to the liver and liver diseases. This year marks its 50th anniversary. It has been highly effect...